Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2010
11/24/2010CN101889679A Composition with disintoxicating and liver-protecting effects and application thereof in food and health-care food
11/24/2010CN101297800B Compound taurine soluble powder for curing hepatitis of dogs and preparation thereof
11/24/2010CN101259259B Preparation of Chinese medicinal composition for treating chronic atrophic gastritis
11/24/2010CN101239158B Chinese medicine for treating appendicitis and preparation thereof
11/24/2010CN101229183B Ribonucleic acid retrogradation snippet compound and applications thereof
11/24/2010CN101152189B Polyene phosphatidyl choline injection and method for preparing the same
11/24/2010CN101120947B Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b
11/24/2010CN101095691B Application of phillyrin in the preparing of medicine for treating or preventing acute and chronic liver injury and hepar fibrosis
11/24/2010CN101057905B Microwave extraction method for cordate houttuynia total flavones
11/24/2010CN101028515B Anti-preisz bacterium and gingival carbon dioxide fibrophilic bacterium mixed IgY and its use in treating ozostomia and gingiva
11/24/2010CN101011569B Method for diagnosing and treating type II dentinogenesis by using DSPP gene and encoding product thereof
11/23/2010US7838541 Methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.
11/23/2010US7838505 using hybrid Hepatocyte Growth Factor (HGF) construct for prevention and treatment of ischemic and liver disorders
11/23/2010US7838289 Assay utilizing multipotent adult stem cells
11/23/2010US7838055 microcrystallization of xylitol and maltitol via spraying liquid feed thereof, evaporating solvent, conditioning, milling; for use in confectionery, foodstuffs, oral hygiene products and pharmaceuticals and dietetic
11/23/2010CA2547378C Edible compositions which are adapted for use by a companion animal
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/23/2010CA2373302C Conditioned cell culture medium compositions and methods of use
11/18/2010WO2010132725A2 Cyclin dependent kinase inhibitors and methods of use
11/18/2010WO2010131994A1 Medicine for dental diseases prophylaxis
11/18/2010WO2010131769A1 Treatment of diffuse-type gastric cancers using s-1 and cisplatin
11/18/2010WO2010131669A1 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
11/18/2010WO2010130799A2 Method for impregnation with supercritical co2
11/18/2010WO2010130685A1 Extract of aerial parts of artichoke and method of production
11/18/2010WO2010130661A1 Prevention and treatment of allergic diarrhoea
11/18/2010WO2010130644A1 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) an antidiabetic compound for use in the treatment of proliferative diseases
11/18/2010WO2010130641A1 Lactoferrin and neuronal health and development in the infant gut
11/18/2010WO2010130622A1 Enzyme composition for the treatment of prancreatic insufficiency
11/18/2010WO2010130460A1 Amorphous silibinin for the treatment of viral hepatitis
11/18/2010US20100292345 Therapeutic uses of cannabigerol
11/18/2010US20100292339 Genetic Polymorphisms Predictive of Nutritional Requirements for Choline in Subjects
11/18/2010US20100292334 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
11/18/2010US20100292314 Anti-angiogenic compositions and methods of use
11/18/2010US20100292304 Compounds and methods for improving cellular uptake of oligomeric compounds
11/18/2010US20100292283 Novel phenyl-acetamide and phenyl-propionamide derivatives useful as potassium channel modulators
11/18/2010US20100292273 Cannabinoid Receptor Modulators
11/18/2010US20100292266 Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase
11/18/2010US20100292252 Vinyl-aryl derivatives for inflammation and immune-related uses
11/18/2010US20100292243 7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
11/18/2010US20100292240 Sulfonamide compounds
11/18/2010US20100292233 Dihydro-1h-pyrrolo[1,2-a]indol-1-yl carboxylic acid derivatives which act as s1p1 agonists
11/18/2010US20100292225 Aryl pyridine as aldosterone synthase inhibitors
11/18/2010US20100292223 Indazole-carboxamide compounds
11/18/2010US20100292208 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010US20100292204 Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
11/18/2010US20100292197 Compositions and Methods for Increasing Telomerase Activity
11/18/2010US20100292172 Peptide-Peptidase Inhibitor Conjugates and Methods of Using Same
11/18/2010US20100292159 Method of treatment or prophylaxis of inflammatory pain
11/18/2010US20100292155 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
11/18/2010US20100292151 Use of human cytokine receptor
11/18/2010US20100291218 Immunomodulatory compositions, formulations, and methods for use thereof
11/18/2010US20100291201 Coated pharmaceutical capsule dosage form
11/18/2010US20100291160 Pharmaceutical system for trans-membrane delivery
11/18/2010US20100291121 Tumour-Specific Animal Proteins
11/18/2010US20100291117 Method for ex-vivo expansion of regulatory t cells with enhanced suppressive function for clinical application in immune mediated diseases
11/18/2010US20100291099 Novel 27411, 23413, 22438, 23553, 25278, 26212, narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, narc 25, 86604 and 32222 molecules and uses therefor
11/18/2010US20100291076 Antibodies specific for dkk-1 and their uses
11/18/2010US20100291052 Novel Microorganism Having Gastric-Juice Promoting Activity, and Its Secretory Product
11/18/2010US20100291051 Agent for prevention of alcoholic hepatopathy
11/18/2010US20100291027 Hyaluronic acid (ha) injection vehicle
11/18/2010CA2761896A1 Cyclin dependent kinase inhibitors and methods of use
11/18/2010CA2761853A1 Benzoxazolone derivatives as aldosterone synthase inhibitors
11/18/2010CA2761656A1 Amorphous silibinin for the treatment of viral hepatitis
11/18/2010CA2761437A1 Lactoferrin and neuronal health and development in the infant gut
11/18/2010CA2761238A1 Prevention and treatment of allergic diarrhoea
11/17/2010EP2251328A1 Crystalline 1-(3-fluorophenyl)-5-methyl-2-(1h)pyridone, the preparation methods, compositions and applications thereof
11/17/2010EP2251031A1 Lactoferrin and neuronal health and development in the infant gut
11/17/2010EP2251029A1 Lactoferrin and gut neuronal health in adults and/or elderly
11/17/2010EP2251021A1 Prevention and treatment of allergic diarrhoea
11/17/2010EP2251019A1 Agent for prevention of alcoholic hepatopathy
11/17/2010EP2251017A1 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration
11/17/2010EP2249852A2 Soluble complexes of curcumin
11/17/2010EP2249794A2 Compositions and methods comprising basic amino acid peptides and proteases
11/17/2010EP2249792A2 Oral care product and methods of use and manufacture thereof
11/17/2010EP2249791A2 Compositions and devices
11/17/2010EP2249790A2 Compositions comprising basic amino acid and soluble carbonate salt
11/17/2010EP2249789A2 Compositions and methods for the treatment of xerostomia
11/17/2010EP2249788A1 Oral care product and methods of use and manufacture thereof
11/17/2010EP2249787A1 Oral care product and methods of use and manufacture thereof
11/17/2010EP2249786A1 Oral care product and methods of use and manufacture thereof
11/17/2010EP2249785A1 Arginine salts and their uses for the treatment of illnesses in the oral cavity
11/17/2010EP2249784A1 Oral care product and methods of use and manufacture thereof
11/17/2010EP2249783A2 Oral care product and methods of use thereof
11/17/2010EP2249776A2 Effervescent compositions
11/17/2010EP2249770A2 Dual component oral care product
11/17/2010EP0773940B2 Process for synthesis of substituted sulphoxides
11/17/2010CN1810803B Method for high enantiomer selection preparation of (S)-Omeprazole
11/17/2010CN1772089B Freeze dried oldenlandia powder for injection and its preparation method
11/17/2010CN101888848A Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
11/17/2010CN101886026A Medicinal liquor for tonifying Qi, nourishing blood, invigorating stomach and presering health and preparation method thereof
11/17/2010CN101885784A Method for producing glucomannan by liquid culture of konjac cells
11/17/2010CN101885770A Fully human antibody capable of specifically bonding CD15 and use thereof
11/17/2010CN101885731A Thiophene derivative
11/17/2010CN101884793A Immune enhanced gene vaccine of hepatitis B virus core antigen and preparation method thereof
11/17/2010CN101884792A Immune enhanced gene vaccine of hepatitis B virus surface antigen and preparation method thereof
11/17/2010CN101884786A Medicament for preventing and treating dental caries
11/17/2010CN101884784A Bv8 nucleic acids and polypeptides with mitogenic activity
11/17/2010CN101884782A Application of bifidobacterium longum adherence inhibition protein Aip for preventing and treating diarrhea
11/17/2010CN101884779A Siberian solomonseal rhizome composition for intervening sub-health state and preparation method thereof
11/17/2010CN101884773A Vomit-preventing traditional Chinese medicine compress bag
1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 1258